Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000464442 | SCV000563825 | pathogenic | Fumarase deficiency | 2016-11-09 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 7-10 of the FH gene. The 5' boundary is likely confined to intron 6. The 3' end of this event is unknown as it extends through the termination codon beyond the assayed region for this gene and may encompass additional genes. While this deletion is not anticipated to result in nonsense mediated decay, it is expected to create a truncated FH protein. While this particular gross deletion has not been reported in the literature, loss-of-function variants in FH are known to be pathogenic (PMID: 11865300, 21398687). Although no functional studies have been performed to test the effect of this particular deletion on FH protein function or stability, several downstream truncating variants have been reported as pathogenic, including a truncating variant (p.Ser480Lysfs*6) disrupting the last 31 amino acids that has been observed in an individual with hereditary leiomyomatosis and renal cell cancer (HLRCC) (PMID: 16881969, 26296701, Invitae). This suggests that C-terminal of the FH protein is critical for the proper protein function. For these reasons, this variant has been classified as Pathogenic. |